We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Loews
L
$24.3B
| $1.01M | 0.01% |
+24,636
| New | +$998K |
|
577
Bausch Health
BHC
$1.65B
| $994K | 0.01% |
5,006
-105,888
| -95% | -$18.8M |
|
578
Public Storage
PSA
$60.2B
| $985K | 0.01% |
4,994
+659
| +15% | +$131K |
|
|
AJRD
579
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $983K | 0.01% |
+42,404
| New | +$818K |
|
580
ICICI Bank
IBN
$106B
| $978K | 0.01% |
103,797
-152,085
| -59% | -$1.58M |
|
|
SINA
581
DELISTED
Sina Corp
SINA
| $971K | 0.01% |
30,194
+4,857
| +19% | +$175K |
|
|
ANR
582
DELISTED
Alpha Natural Resources Inc
ANR
| $970K | 0.01% |
969,932
| – | – |
|
583
Silicon Motion
SIMO
$9.19B
| $967K | 0.01% |
35,990
+15,156
| +73% | +$414K |
|
584
Brunswick
BC
$5.19B
| $959K | 0.01% |
+18,649
| New | +$990K |
|
|
PE
585
DELISTED
PARSLEY ENERGY INC
PE
| $950K | 0.01% |
+59,463
| New | +$930K |
|
586
Dollar Tree
DLTR
$23.1B
| $945K | 0.01% |
11,643
+1,719
| +17% | +$130K |
|
|
DNR
587
DELISTED
Denbury Resources, Inc.
DNR
| $945K | 0.01% |
129,645
-1,701,508
| -93% | -$13.2M |
|
|
LL
588
DELISTED
LL Flooring Holdings, Inc.
LL
| $944K | 0.01% |
+30,655
| New | +$1.57M |
|
589
XPO
XPO
$25B
| $924K | 0.01% |
+58,785
| New | +$852K |
|
590
Landstar System
LSTR
$6.8B
| $913K | 0.01% |
+13,771
| New | +$933K |
|
591
PENN Entertainment
PENN
$2.74B
| $908K | 0.01% |
+57,994
| New | +$911K |
|
592
Bank of America
BAC
$435B
| $895K | 0.01% |
+58,112
| New | +$933K |
|
|
TFCF
593
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $880K | 0.01% |
26,762
+12,570
| +89% | +$422K |
|
594
RH
RH
$3.3B
| $871K | 0.01% |
+8,785
| New | +$797K |
|
|
GRA
595
DELISTED
W.R. Grace & Co.
GRA
| $867K | 0.01% |
8,767
-1,623
| -16% | -$155K |
|
596
Boise Cascade
BCC
$2.74B
| $864K | 0.01% |
+23,086
| New | +$893K |
|
597
Century Aluminum
CENX
$4.57B
| $861K | 0.01% |
+62,425
| New | +$1.26M |
|
|
AVP
598
DELISTED
Avon Products, Inc.
AVP
| $861K | 0.01% |
107,772
-32,791
| -23% | -$272K |
|
599
Thermo Fisher Scientific
TMO
$211B
| $858K | 0.01% |
6,390
+3,607
| +130% | +$465K |
|
|
PKY
600
DELISTED
Parkway, Inc.
PKY
| $850K | 0.01% |
+48,991
| New | +$873K |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.